Involvement of MAPK signalling in human villous trophoblast differentiation

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 8, 2009, Pages 962-973

  Vaillancourt, C ^a,b   Lanoix, D ^a,b   Le Bellego, F ^b   Daoud, G ^c   Lafond, J ^b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cell signalling; Differentiation; Drug; Human placenta; Mitogen activated protein kinases; Peroxisome proliferator activated receptors; Src family kinase; Syncytiotrophoblast; Villous cytotrophoblast

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINO 7 PHENYLPYRAZOL[3,4 D]PYRIMIDINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CHORIONIC GONADOTROPIN; DESMOPLAKIN; FOCAL ADHESION KINASE 1; FOCAL ADHESION KINASE 2; GENISTEIN; HERBIMYCIN A; HUMAN PLACENTA LACTOGEN; LEPTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPEPTIDE Y; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL STRUCTURE; CELL SURVIVAL; CHORION VILLUS; EMBRYO; EMBRYO DEVELOPMENT; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FETAL WELL BEING; FETUS; FETUS DEVELOPMENT; HELLP SYNDROME; HORMONE SYNTHESIS; HUMAN; IMMUNOCYTOCHEMISTRY; NONHUMAN; PATHOPHYSIOLOGY; PLACENTA DEVELOPMENT; PLACENTA VILLUS; PREECLAMPSIA; PREGNANCY; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; SYNCYTIOTROPHOBLAST; TRANSCRIPTION REGULATION; TROPHOBLAST;

EID: 70349096435     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709788681663     Document Type: Review

References (112)

1. Benirschke, K.; Kaufmann, P.; Baergen, R. N. In Pathology of the human placenta; 5th ed.; Benirschke, K., Kaufmann, P., Baergen, R. N., Eds.; Springer: New York, 2006, pp. 50-120.
2. Aplin, J. D. Implantation, trophoblast differentiation and haemochorial placentation: mechanistic evidence in vivo and in vitro. J. Cell. Sci., 1991, 99 (Pt 4), 681-692.
3. Pijnenborg, R.; Bland, J. M.; Robertson, W. B.; Brosens, I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta, 1983, 4, 397-413.
4. Pijnenborg, R.; Bland, J. M.; Robertson, W. B.; Dixon, G.; Brosens, I. The pattern of interstitial trophoblastic invasion of the myometrium in early human pregnancy. Placenta, 1981, 2, 303-16.
5. Kaufmann, P.; Black, S.; Huppertz, B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol. Reprod., 2003, 69, 1-7.
6. Huppertz, B.; Tews, D. S.; Kaufmann, P. Apoptosis and syncytial fusion in human placental trophoblast and skeletal muscle. Int. Rev. Cytol., 2001, 205, 215-53.
7. Vignery, A. Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int J Exp. Pathol., 2000, 81, 291-304.
8. Huppertz, B.; Frank, H. G.; Reister, F.; Kingdom, J.; Korr, H.; Kaufmann, P. Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab. Invest., 1999, 79, 1687-702.
9. Albrecht, E. D.; Pepe, G. J. Placental steroid hormone biosynthesis in primate pregnancy. Endocr. Rev., 1990, 11, 124-50.
10. Pepe, G. J.; Albrecht, E. D. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr. Rev., 1995, 16, 608-48.
11. Senaris, R.; Garcia-Caballero, T.; Casabiell, X.; Gallego, R.; Castro, R.; Considine, R. V.; Dieguez, C.; Casanueva, F. F. Synthesis of leptin in human placenta. Endocrinology, 1997, 138, 4501-4.
12. Alsat, E.; Guibourdenche, J.; Luton, D.; Frankenne, F.; Evain-Brion, D. Human placental growth hormone. Am. J. Obstet. Gynecol., 1997, 177, 1526-34.
13. Handwerger, S. Clinical counterpoint: the physiology of placental lactogen in human pregnancy. Endocr. Rev., 1991, 12, 329-236.
14. Jameson, J. L.; Hollenberg, A. N. Regulation of chorionic gonadotropin gene expression. Endocr. Rev., 1993, 14, 203-221.
15. Petraglia, F.; Calza, L.; Giardino, L.; Sutton, S.; Marrama, P.; Rivier, J.; Genazzani, A. R.; Vale, W. Identification of immunoreactive neuropeptide-gamma in human placenta: localization, secretion, and binding sites. Endocrinology, 1989, 124, 2016-22.
16. Richart, R. Studies of placental morphogenesis. I. Radioautographic studies of human placenta utilizing tritiated thymidine. Proc. Soc. Exp. Biol. Med., 1961, 106, 829-31.
17. Kliman, H. J.; Nestler, J. E.; Sermasi, E.; Sanger, J. M.; Strauss, J. F., 3rd Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology, 1986, 118, 1567-1582.
18. Benirschke, K.; Kaufmann, P.; Baergen, R. N. In Pathology of the human placenta; 5th ed.; Benirschke, K., Kaufmann, P., Baergen, R. N., Eds.; Springer: New York, 2006, pp. 30-41.
19. Midgley, A. R.; Pierce, G. B., Jr.; Deneau, G. A.; Gosling, J. R. Morphogenesis of syncytiotrophoblast in vivo: an autoradiographic demonstration. Science, 1963, 141, 349-50.
20. Morrish, D. W.; Bhardwaj, D.; Dabbagh, L. K.; Marusyk, H.; Siy, O. Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J. Clin. Endocrinol. Metab., 1987, 65, 1282-1290.
21. Strauss, J. F., 3rd; Kido, S.; Sayegh, R.; Sakuragi, N.; Gafvels, M. E. The cAMP signalling system and human trophoblast function. Placenta, 1992, 13, 389-403.
22. Daoud, G.; Amyot, M.; Rassart, E.; Masse, A.; Simoneau, L.; Lafond, J. ERK1/2 and p38 regulate trophoblasts differentiation in human term placenta. J. Physiol., 2005, 566, 409-23.
23. Douglas, G. C.; King, B. F. Differentiation of human trophoblast cells in vitro as revealed by immunocytochemical staining of desmoplakin and nuclei. J. Cell. Sci., 1990, 96 (Pt 1), 131-141.
24. Daoud, G.; Rassart, E.; Masse, A.; Lafond, J. Src family kinases play multiple roles in differentiation of trophoblasts from human term placenta. J. Physiol., 2006, 571, 537-53.
25. Tarrade, A.; Lai Kuen, R.; Malassine, A.; Tricottet, V.; Blain, P.; Vidaud, M.; Evain-Brion, D. Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Lab. Invest., 2001, 81, 1199-211.
26. Kao, L. C.; Caltabiano, S.; Wu, S.; Strauss, J. F., 3rd; Kliman, H. J. The human villous cytotrophoblast: interactions with extracellular matrix proteins, endocrine function, and cytoplasmic differentiation in the absence of syncytium formation. Dev. Biol., 1988, 130, 693-702.
27. Morrish, D. W.; Bhardwaj, D.; Dabbagh, L. K.; Marusyk, H.; Siy, O. Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J. Clin. Endocrinol. Metab., 1987, 65, 1282-90.
28. Garcia-Lloret, M. I.; Morrish, D. W.; Wegmann, T. G.; Honore, L.; Turner, A. R.; Guilbert, L. J. Demonstration of functional cytokine-placental interactions: CSF-1 and GM-CSF stimulate human cytotrophoblast differentiation and peptide hormone secretion. Exp. Cell. Res., 1994, 214, 46-54.
29. Keryer, G.; Alsat, E.; Tasken, K.; Evain-Brion, D. Cyclic AMP-dependent protein kinases and human trophoblast cell differentiation in vitro. J. Cell. Sci., 1998, 111 (Pt 7), 995-1004.
30. Cronier, L.; Guibourdenche, J.; Niger, C.; Malassine, A. Oestradiol stimulates morphological and functional differentiation of human villous cytotrophoblast. Placenta, 1999, 20, 669-76.
31. Shi, Q. J.; Lei, Z. M.; Rao, C. V.; Lin, J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology, 1993, 132, 1387-95.
32. Cronier, L.; Bastide, B.; Herve, J. C.; Deleze, J.; Malassine, A. Gap junctional communication during human trophoblast differentiation: influence of human chorionic gonadotropin. Endocrinology, 1994, 135, 402-8.
33. Yang, M.; Lei, Z. M.; Rao Ch, V. The central role of human chorionic gonadotropin in the formation of human placental syncytium. Endocrinology, 2003, 144, 1108-20.
34. Cronier, L.; Alsat, E.; Hervé, J.; Delèze, J.; Malassiné, A. Dexamethasone stimulates Gap junctional communication peptide hormone production and differentiation in human term trophoblast. Trophoblast Res., 1998, 11, 35-49.
35. Crocker, I. P.; Strachan, B. K.; Lash, G. E.; Cooper, S.; Warren, A. Y.; Baker, P. N. Vascular endothelial growth factor but not placental growth factor promotes trophoblast syncytialization in vitro. J. Soc. Gynecol. Investig., 2001, 8, 341-6.
36. Alsat, E.; Wyplosz, P.; Malassine, A.; Guibourdenche, J.; Porquet, D.; Nessmann, C.; Evain-Brion, D. Hypoxia impairs cell fusion and differentiation process in human cytotrophoblast, in vitro. J. Cell. Physiol., 1996, 168, 346-53.
37. Morrish, D. W.; Shaw, A. R.; Seehafer, J.; Bhardwaj, D.; Paras, M. T. Preparation of fibroblast-free cytotrophoblast cultures utilizing differential expression of the CD9 antigen. In Vitro Cell. Dev. Biol., 1991, 27A, 303-6.
38. Leisser, C.; Saleh, L.; Haider, S.; Husslein, H.; Sonderegger, S.; Knofler, M. Tumour necrosis factor-alpha impairs chorionic gonadotrophin beta-subunit expression and cell fusion of human villous cytotrophoblast. Mol. Hum. Reprod., 2006, 12, 601-9.
39. Cronier, L.; Dubut, A.; Guibourdenche, J.; Malassine, A. Effects of endothelin on villous trophoblast differentiation and free intracellular calcium. Trophoblast Res., 1999, 13, 69-86.
40. Cronier, L.; Frendo, J. L.; Defamie, N.; Pidoux, G.; Bertin, G.; Guibourdenche, J.; Pointis, G.; Malassine, A. Requirement of gap junctional intercellular communication for human villous trophoblast differentiation. Biol. Reprod., 2003, 69, 1472-80.
41. Frendo, J. L.; Cronier, L.; Bertin, G.; Guibourdenche, J.; Vidaud, M.; Evain-Brion, D.; Malassine, A. Involvement of connexin 43 in human trophoblast cell fusion and differentiation. J. Cell. Sci., 2003, 116, 3413-21.
42. Adler, R.R.; Ng, A.K.; Rote, N.S. Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol. Reprod., 1995, 53, 905-10.
43. Cronier, L.; Defamie, N.; Dupays, L.; Theveniau-Ruissy, M.; Goffin, F.; Pointis, G.; Malassine, A. Connexin expression and gap junctional intercellular communication in human first trimester trophoblast. Mol. Hum. Reprod., 2002, 8, 1005-13.
44. Getsios, S.; MacCalman, C. D. Cadherin-11 modulates the terminal differentiation and fusion of human trophoblastic cells in vitro. Dev. Biol., 2003, 257, 41-54.
45. MacCalman, C. D.; Furth, E. E.; Omigbodun, A.; Bronner, M.; Coutifaris, C.; Strauss, J. F., 3rd Regulated expression of cadherin-11 in human epithelial cells: a role for cadherin-11 in trophoblastendometrium interactions? Dev. Dyn., 1996, 206, 201-11.
46. Kudo, Y.; Boyd, C. A. RNA interference-induced reduction in CD98 expression suppresses cell fusion during syncytialization of human placental BeWo cells. FEBS. Lett., 2004, 577, 473-7.
47. Huppertz, B.; Bartz, C.; Kokozidou, M. Trophoblast fusion: fusogenic proteins, syncytins and ADAMs, and other prerequisites for syncytial fusion. Micron, 2006, 37, 509-17.
48. Huovila, A. P.; Almeida, E. A.; White, J. M. ADAMs and cell fusion. Curr. Opin. Cell. Biol., 1996, 8, 692-9.
49. Stone, A. L.; Kroeger, M.; Sang, Q. X. Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase-containing proteins (review). J. Protein Chem., 1999, 18, 447-65.
50. Fischer, U.; Janicke, R. U.; Schulze-Osthoff, K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell. Death. Differ., 2003, 10, 76-100.
51. Black, S.; Kadyrov, M.; Kaufmann, P.; Ugele, B.; Emans, N.; Huppertz, B. Syncytial fusion of human trophoblast depends on caspase 8. Cell. Death. Differ., 2003, 11, 90-98.
52. White, L.; Dharmarajan, A.; Charles, A. Caspase-14: a new player in cytotrophoblast differentiation. Reprod. Biomed. Online, 2007, 14, 300-7.
53. Guibourdenche, J.; Frendo, J. L.; Pidoux, G.; Bertin, G.; Luton, D.; Muller, F.; Porquet, D.; Evain-Brion, D. Expression of pregnancy-associated plasma protein-A (PAPP-A) during human villous trophoblast differentiation in vitro. Placenta, 2003, 24, 532-9.
54. Keith, J. C., Jr.; Pijnenborg, R.; Van Assche, F. A. Placental syncytin expression in normal and preeclamptic pregnancies. Am. J. Obstet. Gynecol., 2002, 187, 1122-3; author reply 1123-4.
55. Knerr, I.; Beinder, E.; Rascher, W. Syncytin, a novel human endogenous retroviral gene in human placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome. Am. J. Obstet. Gynecol., 2002, 186, 210-3.
56. Lee, X.; Keith, J. C., Jr.; Stumm, N.; Moutsatsos, I.; McCoy, J. M.; Crum, C. P.; Genest, D.; Chin, D.; Ehrenfels, C.; Pijnenborg, R.; van Assche, F. A.; Mi, S. Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia. Placenta, 2001, 22, 808-12.
57. Redman, C. W.; Sargent, I. L. Latest advances in understanding preeclampsia. Science, 2005, 308, 1592-4.
58. Zhou, Y.; McMaster, M.; Woo, K.; Janatpour, M.; Perry, J.; Karpanen, T.; Alitalo, K.; Damsky, C.; Fisher, S. J. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am. J. Pathol., 2002, 160, 1405-23.
59. Evain-Brion, D.; Frendo, J. L.; Vidaud, M.; Muller, F.; Porquet, D.; Blot, P. [Failure of differentiation of the trophoblast in trisomy 21]. Bull. Acad. Natl. Med., 2000, 184, 1033-45; discussion 1045-7.
60. Frendo, J. L.; Vidaud, M.; Guibourdenche, J.; Luton, D.; Muller, F.; Bellet, D.; Giovagrandi, Y.; Tarrade, A.; Porquet, D.; Blot, P.; Evain-Brion, D. Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome. J. Clin. Endocrinol. Metab., 2000, 85, 3700-7.
61. Bose, P.; Kadyrov, M.; Goldin, R.; Hahn, S.; Backos, M.; Regan, L.; Huppertz, B. Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. Placenta, 2006, 27, 869-75.
62. Chen, Z.; Gibson, T. B.; Robinson, F.; Silvestro, L.; Pearson, G.; Xu, B.; Wright, A.; Vanderbilt, C.; Cobb, M. H. MAP kinases. Chem. Rev., 2001, 101, 2449-76.
63. Kyriakis, J. M.; Avruch, J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev., 2001, 81, 807-69.
64. Pearson, G.; Robinson, F.; Beers Gibson, T.; Xu, B. E.; Karandikar, M.; Berman, K.; Cobb, M. H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev., 2001, 22, 153-83.
65. Aubert, J.; Belmonte, N.; Dani, C. Role of pathways for signal transducers and activators of transcription, and mitogen-activated protein kinase in adipocyte differentiation. Cell. Mol. Life. Sci.,1999, 56, 538-42.
66. Eriksson, M.; Leppa, S. Mitogen-activated protein kinases and activator protein 1 are required for proliferation and cardiomyocyte differentiation of P19 embryonal carcinoma cells. J. Biol. Chem., 2002, 277, 15992-6001.
67. Hoffman, L. M.; Weston, A. D.; Underhill, T. M. Molecular mechanisms regulating chondroblast differentiation. J. Bone Joint Surg. Am., 2003, 85-A Suppl 2, 124-32.
68. Keren, A.; Tamir, Y.; Bengal, E. The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol. Cell. Endocrinol., 2006, 252, 224-30.
69. Frebel, K.; Wiese, S. Signalling molecules essential for neuronal survival and differentiation. Biochem. Soc. Trans., 2006, 34, 1287-90.
70. Nebreda, A. R.; Porras, A. p38 MAP kinases: beyond the stress response. Trends Biochem. Sci., 2000, 25, 257-60.
71. Alessi, D. R.; Cuenda, A.; Cohen, P.; Dudley, D. T.; Saltiel, A. R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 1995, 270, 27489-94.
72. DeSilva, D. R.; Jones, E. A.; Favata, M. F.; Jaffee, B. D.; Magolda, R. L.; Trzaskos, J. M.; Scherle, P. A. Inhibition of mitogenactivated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J. Immunol., 1998, 160, 4175-81.
73. Young, P. R.; McLaughlin, M. M.; Kumar, S.; Kassis, S.; Doyle, M. L.; McNulty, D.; Gallagher, T. F.; Fisher, S.; McDonnell, P. C.; Carr, S. A.; Huddleston, M. J.; Seibel, G.; Porter, T. G.; Livi, G. P.; Adams, J. L.; Lee, J. C. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J. Biol. Chem., 1997, 272, 12116-21.
74. Lee, J. C.; Laydon, J. T.; McDonnell, P. C.; Gallagher, T. F.; Kumar, S.; Green, D.; McNulty, D.; Blumenthal, M. J.; Heys, J. R.; Landvatter, S. W.; et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature, 1994, 372, 739-46.
75. Davies, S. P.; Reddy, H.; Caivano, M.; Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J., 2000, 351, 95-105.
76. Mudgett, J. S.; Ding, J.; Guh-Siesel, L.; Chartrain, N. A.; Yang, L.; Gopal, S.; Shen, M. M. Essential role for p38alpha mitogenactivated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 10454-9.
77. Saba-El-Leil, M. K.; Vella, F. D.; Vernay, B.; Voisin, L.; Chen, L.; Labrecque, N.; Ang, S. L.; Meloche, S. An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO. Rep., 2003, 4, 964-8.
78. Kita, N.; Mitsushita, J.; Ohira, S.; Takagi, Y.; Ashida, T.; Kanai, M.; Nikaido, T.; Konishi, I. Expression and activation of MAP kinases, ERK1/ 2, in the human villous trophoblasts. Placenta, 2003, 24, 164-72.
79. Hunter, T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 1998, 353, 583-605.
80. Thomas, S. M.; Brugge, J. S. Cellular functions regulated by Src family kinases. Annu Rev Cell. Dev. Biol., 1997, 13, 513-609.
81. Bolen, J. B.; Brugge, J. S. Leukocyte protein tyrosine kinases: potential targets for drug discovery. Annu. Rev. Immunol., 1997, 15, 371-404.
82. Lowell, C. A. Src-family kinases: rheostats of immune cell signaling. Mol. Immunol., 2004, 41, 631-43.
83. Schwartzberg, P. L. The many faces of Src: multiple functions of a prototypical tyrosine kinase. Oncogene, 1998, 17, 1463-8.
84. Uehara, Y.; Fukazawa, H.; Murakami, Y.; Mizuno, S. Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds. Biochem. Biophys. Res. Commun., 1989, 163, 803-9.
85. Chong, Y. P.; Ia, K. K.; Mulhern, T. D.; Cheng, H. C. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases. Biochim. Biophys. Acta, 2005, 1754, 210-20.
86. Liu, Y.; Bishop, A.; Witucki, L.; Kraybill, B.; Shimizu, E.; Tsien, J.; Ubersax, J.; Blethrow, J.; Morgan, D. O.; Shokat, K. M. Structural basis for selective inhibition of Src family kinases by PP1. Chem. Biol., 1999, 6, 671-8.
87. Hanke, J. H.; Gardner, J. P.; Dow, R. L.; Changelian, P. S.; Brissette, W. H.; Weringer, E. J.; Pollok, B. A.; Connelly, P. A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem., 1996, 271, 695-701.
88. Traxler, P.; Bold, G.; Frei, J.; Lang, M.; Lydon, N.; Mett, H.; Buchdunger, E.; Meyer, T.; Mueller, M.; Furet, P. Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. J. Med. Chem., 1997, 40, 3601-16.
89. Kamei, T.; Hamlin, G. P.; Chapman, B. M.; Burkhardt, A. L.; Bolen, J. B.; Soares, M. J. Signaling pathways controlling trophoblast cell differentiation: Src family protein tyrosine kinases in the rat. Biol. Reprod., 1997, 57, 1302-11.
90. Park, J. S.; Namkoong, S. E.; Lee, H. Y.; Kim, S. J.; Hong, K. J.; Kim, I. S.; Kim, K. U.; Shim, B. S. Expression and amplification of cellular oncogenes in human developing placenta and neoplastic trophoblastic tissue. Asia Oceania J. Obstet. Gynaecol., 1992, 18, 57-64.
91. Daoud, G.; LeBellego, F.; Lafond, J. PP2 regulates human trophoblast cells differentiation by activating p38 and ERK1/2 and inhibiting FAK activation. Placenta, 2008, 29, 862-70.
92. Pollheimer, J.; Knofler, M. Signalling pathways regulating the invasive differentiation of human trophoblasts: a review. Placenta, 2005, 26 (Suppl A), S21-30.
93. Schaller, M. D. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta, 2001, 1540, 1-21.
94. Li, X.; Hunter, D.; Morris, J.; Haskill, J. S.; Earp, H. S. A calciumdependent tyrosine kinase splice variant in human monocytes. Activation by a two-stage process involving adherence and a subsequent intracellular signal. J. Biol. Chem., 1998, 273, 9361-4.
95. Cox, B. D.; Natarajan, M.; Stettner, M. R.; Gladson, C. L. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J. Cell. Biochem., 2006, 99, 35-52.
96. Hanks, S. K.; Polte, T. R. Signaling through focal adhesion kinase. Bioessays, 1997, 19, 137-45.
97. MacPhee, D. J.; Mostachfi, H.; Han, R.; Lye, S. J.; Post, M.; Caniggia, I. Focal adhesion kinase is a key mediator of human trophoblast development. Lab. Invest., 2001, 81, 1469-83.
98. Nada, S.; Okada, M.; MacAuley, A.; Cooper, J. A.; Nakagawa, H. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60csrc. Nature, 1991, 351, 69-72.
99. Chong, Y. P.; Mulhern, T. D.; Cheng, H. C. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK) - endogenous negative regulators of Src-family protein kinases. Growth Factors, 2005, 23, 233-44.
100. Hakak, Y.; Martin, G. S. Ubiquitin-dependent degradation of active Src. Curr. Biol., 1999, 9, 1039-42.
101. Ralston, A.; Rossant, J. How signaling promotes stem cell survival: trophoblast stem cells and Shp2. Dev. Cell., 2006, 10, 275-6.
102. Yang, W.; Klaman, L. D.; Chen, B.; Araki, T.; Harada, H.; Thomas, S. M.; George, E. L.; Neel, B. G. An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev. Cell., 2006, 10, 317-27.
103. Arman, E.; Haffner-Krausz, R.; Chen, Y.; Heath, J. K.; Lonai, P. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl. Acad. Sci. USA, 1998, 95, 5082-7.
104. Johnstone, E. D.; Sibley, C. P.; Lowen, B.; Guilbert, L. J. Epidermal growth factor stimulation of trophoblast differentiation requires MAPK11/ 14 (p38 MAP kinase) activation. Biol. Reprod., 2005, 73, 1282-8.
105. Fournier, T.; Tsatsaris, V.; Handschuh, K.; Evain-Brion, D. PPARs and the placenta. Placenta, 2007, 28, 65-76.
106. Daoud, G.; Simoneau, L.; Masse, A.; Rassart, E.; Lafond, J. Expression of cFABP and PPAR in trophoblast cells: effect of PPAR ligands on linoleic acid uptake and differentiation. Biochim. Biophys. Acta, 2005, 1687, 181-94.
107. Xu, Y.; Wang, Q.; Cook, T. J.; Knipp, G. T. Effect of placental fatty acid metabolism and regulation by peroxisome proliferator activated receptor on pregnancy and fetal outcomes. J. Pharm. Sci., 2007, 96, 2582-606.
108. Schaiff, W. T.; Barak, Y.; Sadovsky, Y. The pleiotropic function of PPAR gamma in the placenta. Mol. Cell. Endocrinol., 2006, 249, 10-5.
109. Tarrade, A.; Schoonjans, K.; Guibourdenche, J.; Bidart, J. M.; Vidaud, M.; Auwerx, J.; Rochette-Egly, C.; Evain-Brion, D. PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology, 2001, 142, 4504-14.
110. Barak, Y.; Nelson, M. C.; Ong, E. S.; Jones, Y. Z.; Ruiz-Lozano, P.; Chien, K. R.; Koder, A.; Evans, R. M. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell., 1999, 4, 585-95.
111. Schild, R. L.; Sonnenberg-Hirche, C. M.; Schaiff, W. T.; Bildirici, I.; Nelson, D. M.; Sadovsky, Y. The kinase p38 regulates peroxisome proliferator activated receptor-gamma in human trophoblasts. Placenta, 2006, 27, 191-9.
112. Hannke-Lohmann, A.; Pildner von Steinburg, S.; Dehne, K.; Benard, V.; Kolben, M.; Schmitt, M.; Lengyel, E. Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia. Obstet. Gynecol., 2000, 96, 582-7.